Skip to content

Rock Springs Capital Management LP

Follow

13F filer, CIK 1595725, Baltimore, MD

Rock Springs Capital Management LP reported $1,859,870,981 across 107 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 42.94% of the portfolio.

Accepted , ingested 13F-HR 0001172661-26-005279

Period
2026-09-30
Reported value
$1.86B
Holdings
107
Top 10 weight
42.94%
New
12
Sold out
9

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LTGOnew+654,497$10.9M
FRNMnew+677,220$10.7M
UNHadded+28,500$10.5M
AMLXadded+257,010$7.48M
ABCLnew+275,000$4.01M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RVMDreduced-235,954-$48.4M
ARGXreduced-22,750-$21.8M
PENreduced-55,750-$17.7M
ALNYreduced-28,750-$7.09M
AZTAreduced-200,250-$6.99M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001172661-26-005279, largest first. % of portfolio is the value over $1,859,870,981, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,213,257 shares; 2025Q1: 1,281,640 shares; 2025Q2: 1,330,960 shares; 2025Q3: 1,335,270 shares; 2025Q4: 1,335,270 shares; 2026Q1: 1,209,465 shares; 2026Q2: 1,105,210 shares; 2026Q3: 869,256 shares 869,256$178M9.59%-235,954Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,973,649 shares; 2025Q1: 2,921,196 shares; 2025Q2: 1,908,208 shares; 2025Q3: 2,164,773 shares; 2025Q4: 2,210,322 shares; 2026Q1: 1,477,954 shares; 2026Q2: 2,179,069 shares; 2026Q3: 2,204,085 shares 2,204,085$130M6.98%+25,016Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 144,500 shares; 2025Q1: 113,500 shares; 2025Q2: 116,500 shares; 2025Q3: 105,400 shares; 2025Q4: 105,400 shares; 2026Q1: 98,700 shares; 2026Q2: 98,700 shares; 2026Q3: 98,700 shares 98,700$114M6.14%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 265,212 shares; 2025Q1: 166,698 shares; 2025Q2: 140,296 shares; 2025Q3: 137,746 shares; 2025Q4: 139,618 shares; 2026Q1: 170,999 shares; 2026Q2: 174,999 shares; 2026Q3: 177,249 shares 177,249$89.3M4.8%+2,250Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,471,564 shares; 2025Q1: 951,765 shares; 2025Q2: 818,206 shares; 2025Q3: 761,126 shares; 2025Q4: 762,294 shares; 2026Q1: 811,294 shares; 2026Q2: 798,145 shares; 2026Q3: 779,790 shares 779,790$66.7M3.58%-18,355Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,162,718 shares; 2025Q1: 834,188 shares; 2025Q2: 861,153 shares; 2025Q3: 717,102 shares; 2025Q4: 695,010 shares; 2026Q1: 689,748 shares; 2026Q2: 692,598 shares; 2026Q3: 692,598 shares 692,598$65.9M3.55%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,034,137 shares; 2025Q1: 794,437 shares; 2025Q2: 450,374 shares; 2025Q3: 450,374 shares; 2025Q4: 496,871 shares; 2026Q1: 496,871 shares; 2026Q2: 453,156 shares; 2026Q3: 409,631 shares 409,631$45.8M2.46%-43,525Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 550,000 shares; 2025Q1: 515,900 shares; 2025Q2: 525,000 shares; 2025Q3: 385,000 shares; 2025Q4: 319,250 shares; 2026Q1: 314,300 shares; 2026Q2: 362,150 shares; 2026Q3: 365,250 shares 365,250$41.7M2.24%+3,100Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 176,000 shares; 2025Q1: 100,500 shares; 2025Q2: 50,500 shares; 2025Q3: not reported; 2025Q4: 40,800 shares; 2026Q1: 53,000 shares; 2026Q2: 63,750 shares; 2026Q3: 92,250 shares 92,250$33.9M1.82%+28,500Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 716,782 shares; 2025Q1: 761,541 shares; 2025Q2: 794,133 shares; 2025Q3: 794,133 shares; 2025Q4: 733,477 shares; 2026Q1: 739,816 shares; 2026Q2: 715,452 shares; 2026Q3: 682,654 shares 682,654$33M1.77%-32,798Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 168,750 shares; 2026Q3: 144,000 shares 144,000$32.8M1.76%-24,750Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 129,200 shares; 2025Q1: 130,000 shares; 2025Q2: 130,000 shares; 2025Q3: 125,000 shares; 2025Q4: 125,000 shares; 2026Q1: 125,000 shares; 2026Q2: 125,000 shares; 2026Q3: 125,000 shares 125,000$31.9M1.72%0Timeline
MMEDMINIMED GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,055,000 shares; 2026Q2: 1,520,000 shares; 2026Q3: 1,605,000 shares 1,605,000$31.2M1.68%+85,000Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 397,500 shares; 2025Q1: 254,300 shares; 2025Q2: 242,500 shares; 2025Q3: 235,000 shares; 2025Q4: 235,000 shares; 2026Q1: 261,750 shares; 2026Q2: 269,650 shares; 2026Q3: 273,950 shares 273,950$31.1M1.67%+4,300Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 216,000 shares; 2025Q1: 102,000 shares; 2025Q2: 82,000 shares; 2025Q3: 82,000 shares; 2025Q4: 82,000 shares; 2026Q1: 82,000 shares; 2026Q2: 76,460 shares; 2026Q3: 72,250 shares 72,250$29.4M1.58%-4,210Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 229,600 shares; 2025Q1: 175,750 shares; 2025Q2: 175,750 shares; 2025Q3: 142,750 shares; 2025Q4: 103,250 shares; 2026Q1: 98,500 shares; 2026Q2: 52,750 shares; 2026Q3: 30,000 shares 30,000$28.8M1.55%-22,750Timeline
HTFLHEARTFLOW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,000 shares; 2025Q4: 277,700 shares; 2026Q1: 572,500 shares; 2026Q2: 573,500 shares; 2026Q3: 575,000 shares 575,000$28.6M1.54%+1,500Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 353,000 shares; 2025Q1: 397,650 shares; 2025Q2: 286,750 shares; 2025Q3: 316,900 shares; 2025Q4: 347,300 shares; 2026Q1: 355,600 shares; 2026Q2: 343,000 shares; 2026Q3: 293,500 shares 293,500$25.3M1.36%-49,500Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 460,000 shares; 2025Q1: 277,000 shares; 2025Q2: 355,000 shares; 2025Q3: 360,250 shares; 2025Q4: 399,050 shares; 2026Q1: 515,300 shares; 2026Q2: 528,500 shares; 2026Q3: 535,000 shares 535,000$23.4M1.26%+6,500Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 110,889 shares; 2025Q1: 354,376 shares; 2025Q2: 373,750 shares; 2025Q3: 288,344 shares; 2025Q4: 260,344 shares; 2026Q1: 225,179 shares; 2026Q2: 277,087 shares; 2026Q3: 285,122 shares 285,122$22.4M1.21%+8,035Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 343,228 shares; 2025Q2: 499,764 shares; 2025Q3: 499,764 shares; 2025Q4: 499,764 shares; 2026Q1: 499,764 shares; 2026Q2: 499,764 shares; 2026Q3: 756,774 shares 756,774$22M1.18%+257,010Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,222,182 shares; 2025Q1: 812,653 shares; 2025Q2: 812,653 shares; 2025Q3: 721,538 shares; 2025Q4: 692,538 shares; 2026Q1: 650,270 shares; 2026Q2: 699,146 shares; 2026Q3: 653,344 shares 653,344$21.2M1.14%-45,802Timeline
AGLAGILON HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 260,000 shares; 2026Q2: 262,600 shares; 2026Q3: 262,500 shares 262,500$20.9M1.12%-100Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,305,337 shares; 2025Q1: 904,592 shares; 2025Q2: 871,392 shares; 2025Q3: 791,193 shares; 2025Q4: 811,546 shares; 2026Q1: 814,707 shares; 2026Q2: 814,707 shares; 2026Q3: 791,307 shares 791,307$20.8M1.12%-23,400Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 951,710 shares; 2026Q1: 1,103,469 shares; 2026Q2: 1,402,150 shares; 2026Q3: 1,405,393 shares 1,405,393$20.6M1.11%+3,243Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 775,131 shares; 2025Q1: 623,402 shares; 2025Q2: 623,402 shares; 2025Q3: 623,402 shares; 2025Q4: 623,402 shares; 2026Q1: 645,533 shares; 2026Q2: 648,333 shares; 2026Q3: 648,333 shares 648,333$20.6M1.11%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,080,963 shares; 2025Q1: 1,132,979 shares; 2025Q2: 1,135,879 shares; 2025Q3: 951,154 shares; 2025Q4: 748,236 shares; 2026Q1: 640,217 shares; 2026Q2: 640,317 shares; 2026Q3: 640,317 shares 640,317$20M1.08%0Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,204,309 shares; 2025Q1: 5,046,309 shares; 2025Q2: 4,769,309 shares; 2025Q3: 4,609,309 shares; 2025Q4: 4,453,741 shares; 2026Q1: 4,472,650 shares; 2026Q2: 4,330,532 shares; 2026Q3: 3,791,117 shares 3,791,117$19.9M1.07%-539,415Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,251,859 shares; 2025Q1: 931,681 shares; 2025Q2: 931,681 shares; 2025Q3: 851,744 shares; 2025Q4: 787,788 shares; 2026Q1: 763,020 shares; 2026Q2: 683,907 shares; 2026Q3: 524,758 shares 524,758$19.5M1.05%-159,149Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 240,000 shares; 2025Q1: 171,000 shares; 2025Q2: 128,500 shares; 2025Q3: 120,500 shares; 2025Q4: 120,500 shares; 2026Q1: 120,500 shares; 2026Q2: 115,750 shares; 2026Q3: 60,000 shares 60,000$19.1M1.03%-55,750Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 662,918 shares; 2026Q3: 662,918 shares 662,918$18.9M1.02%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 578,028 shares; 2026Q3: 577,281 shares 577,281$18.6M1%-747Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 720,500 shares; 2025Q1: 279,000 shares; 2025Q2: 88,800 shares; 2025Q3: 89,750 shares; 2025Q4: 125,500 shares; 2026Q1: 150,450 shares; 2026Q2: 144,750 shares; 2026Q3: 130,500 shares 130,500$18.5M1%-14,250Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 428,571 shares; 2025Q1: 465,871 shares; 2025Q2: 701,408 shares; 2025Q3: 686,107 shares; 2025Q4: 798,405 shares; 2026Q1: 826,500 shares; 2026Q2: 464,625 shares; 2026Q3: 393,659 shares 393,659$18M0.97%-70,966Timeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 575,432 shares; 2026Q3: 575,432 shares 575,432$17.7M0.95%0Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 130,000 shares; 2025Q1: 99,250 shares; 2025Q2: 107,500 shares; 2025Q3: 110,500 shares; 2025Q4: 131,000 shares; 2026Q1: 131,800 shares; 2026Q2: 244,000 shares; 2026Q3: 244,000 shares 244,000$16.9M0.91%0Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 58,800 shares; 2025Q2: 59,000 shares; 2025Q3: 61,500 shares; 2025Q4: 61,500 shares; 2026Q1: 61,500 shares; 2026Q2: 76,300 shares; 2026Q3: 76,300 shares 76,300$16.9M0.91%0Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 282,624 shares; 2025Q4: 282,624 shares; 2026Q1: 287,967 shares; 2026Q2: 298,218 shares; 2026Q3: 275,347 shares 275,347$16.1M0.87%-22,871Timeline
OMEROMEROS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 718,499 shares; 2026Q3: 847,206 shares 847,206$16.1M0.87%+128,707Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 471,086 shares; 2025Q1: 342,180 shares; 2025Q2: 989,745 shares; 2025Q3: 958,542 shares; 2025Q4: 799,163 shares; 2026Q1: 799,163 shares; 2026Q2: 532,563 shares; 2026Q3: 472,335 shares 472,335$15.7M0.84%-60,228Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 767,522 shares; 2025Q1: 536,111 shares; 2025Q2: 536,111 shares; 2025Q3: 595,929 shares; 2025Q4: 557,194 shares; 2026Q1: 588,794 shares; 2026Q2: 582,744 shares; 2026Q3: 613,942 shares 613,942$14.9M0.8%+31,198Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 474,528 shares; 2025Q1: 524,499 shares; 2025Q2: 580,998 shares; 2025Q3: 824,061 shares; 2025Q4: 912,955 shares; 2026Q1: 972,198 shares; 2026Q2: 942,154 shares; 2026Q3: 891,869 shares 891,869$14.4M0.77%-50,285Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,739,813 shares; 2025Q1: 1,394,434 shares; 2025Q2: 1,391,072 shares; 2025Q3: 1,246,341 shares; 2025Q4: 1,267,241 shares; 2026Q1: 1,218,773 shares; 2026Q2: 967,855 shares; 2026Q3: 925,089 shares 925,089$13.9M0.75%-42,766Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 878,667 shares; 2025Q1: 878,667 shares; 2025Q2: 640,467 shares; 2025Q3: 580,677 shares; 2025Q4: 502,077 shares; 2026Q1: 502,077 shares; 2026Q2: 502,077 shares; 2026Q3: 502,077 shares 502,077$13.5M0.73%0Timeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 793,651 shares; 2025Q3: 793,651 shares; 2025Q4: 687,500 shares; 2026Q1: 563,000 shares; 2026Q2: 487,500 shares; 2026Q3: 438,500 shares 438,500$13.4M0.72%-49,000Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,853 shares; 2026Q1: 45,364 shares; 2026Q2: 187,980 shares; 2026Q3: 201,839 shares 201,839$13.3M0.72%+13,859Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 85,000 shares; 2025Q4: 103,500 shares; 2026Q1: 128,250 shares; 2026Q2: 144,750 shares; 2026Q3: 192,250 shares 192,250$12.7M0.68%+47,500Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 800,199 shares; 2025Q3: 1,008,308 shares; 2025Q4: 849,030 shares; 2026Q1: 624,155 shares; 2026Q2: 515,917 shares; 2026Q3: 389,363 shares 389,363$12.5M0.67%-126,554Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 320,813 shares; 2025Q2: 324,513 shares; 2025Q3: 408,313 shares; 2025Q4: 427,596 shares; 2026Q1: 439,751 shares; 2026Q2: 484,951 shares; 2026Q3: 484,951 shares 484,951$12.2M0.66%0Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,054,000 shares; 2025Q1: 995,000 shares; 2025Q2: 710,000 shares; 2025Q3: 710,000 shares; 2025Q4: 710,000 shares; 2026Q1: 710,000 shares; 2026Q2: 715,000 shares; 2026Q3: 715,000 shares 715,000$12.1M0.65%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 487,863 shares; 2025Q1: 520,796 shares; 2025Q2: 617,396 shares; 2025Q3: 617,396 shares; 2025Q4: 568,579 shares; 2026Q1: 503,585 shares; 2026Q2: 427,584 shares; 2026Q3: 356,206 shares 356,206$11.5M0.62%-71,378Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 386,915 shares; 2026Q1: 386,915 shares; 2026Q2: 456,551 shares; 2026Q3: 460,031 shares 460,031$11.5M0.62%+3,480Timeline
LTGOLATIGO BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 654,497 shares 654,497$10.9M0.59%newTimeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 61,879 shares; 2026Q1: 161,798 shares; 2026Q2: 162,298 shares; 2026Q3: 166,548 shares 166,548$10.8M0.58%+4,250Timeline
FRNMFREENOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 677,220 shares 677,220$10.7M0.57%newTimeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 445,975 shares; 2025Q1: 336,070 shares; 2025Q2: 336,070 shares; 2025Q3: 370,666 shares; 2025Q4: 429,095 shares; 2026Q1: 489,095 shares; 2026Q2: 535,286 shares; 2026Q3: 535,286 shares 535,286$9.96M0.54%0Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 256,200 shares; 2025Q1: 143,250 shares; 2025Q2: 100,000 shares; 2025Q3: 74,250 shares; 2025Q4: 71,250 shares; 2026Q1: 74,000 shares; 2026Q2: 66,750 shares; 2026Q3: 38,000 shares 38,000$9.38M0.5%-28,750Timeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 245,500 shares; 2026Q3: 256,500 shares 256,500$9.2M0.49%+11,000Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 14,800 shares; 2026Q2: 29,000 shares; 2026Q3: 32,300 shares 32,300$8.9M0.48%+3,300Timeline
EVHEVOLENT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,060,000 shares; 2025Q1: 2,695,700 shares; 2025Q2: 2,820,700 shares; 2025Q3: 2,950,000 shares; 2025Q4: 2,675,000 shares; 2026Q1: 2,675,000 shares; 2026Q2: 2,500,000 shares; 2026Q3: 2,380,000 shares 2,380,000$8.31M0.45%-120,000Timeline
CORTCORCEPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,250 shares; 2026Q1: 50,250 shares; 2026Q2: 72,000 shares; 2026Q3: 72,000 shares 72,000$8.3M0.45%0Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,463,629 shares; 2025Q1: 1,604,975 shares; 2025Q2: 2,286,273 shares; 2025Q3: 2,286,273 shares; 2025Q4: 2,299,473 shares; 2026Q1: 2,299,473 shares; 2026Q2: 2,241,769 shares; 2026Q3: 2,369,869 shares 2,369,869$8.1M0.44%+128,100Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 106,537 shares; 2025Q4: 139,228 shares; 2026Q1: 183,986 shares; 2026Q2: 199,811 shares; 2026Q3: 199,811 shares 199,811$8.1M0.44%0Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 347,666 shares; 2026Q1: 347,666 shares; 2026Q2: 347,666 shares; 2026Q3: 367,354 shares 367,354$7.9M0.42%+19,688Timeline
PHRPHREESIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,040,000 shares; 2025Q1: 1,148,336 shares; 2025Q2: 837,300 shares; 2025Q3: 749,116 shares; 2025Q4: 876,600 shares; 2026Q1: 600,400 shares; 2026Q2: 696,900 shares; 2026Q3: 748,500 shares 748,500$7.73M0.42%+51,600Timeline
AZTAAZENTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 475,000 shares; 2025Q1: 475,000 shares; 2025Q2: 530,400 shares; 2025Q3: 540,400 shares; 2025Q4: 569,100 shares; 2026Q1: 569,100 shares; 2026Q2: 403,000 shares; 2026Q3: 202,750 shares 202,750$7.07M0.38%-200,250Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000$6.75M0.36%0Timeline
FOCLEDAP TMS S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,591,800 shares; 2025Q1: 1,270,000 shares; 2025Q2: 1,270,000 shares; 2025Q3: 1,270,000 shares; 2025Q4: 1,286,500 shares; 2026Q1: 1,378,000 shares; 2026Q2: 1,386,000 shares; 2026Q3: 1,450,000 shares 1,450,000$6.48M0.35%+64,000Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 204,466 shares; 2025Q1: 204,466 shares; 2025Q2: 210,266 shares; 2025Q3: 210,366 shares; 2025Q4: 358,798 shares; 2026Q1: 367,009 shares; 2026Q2: 367,009 shares; 2026Q3: 367,009 shares 367,009$6.34M0.34%0Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 143,187 shares; 2026Q3: 154,188 shares 154,188$5.87M0.32%+11,001Timeline
OMDAOMADA HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 919,951 shares; 2025Q3: 919,950 shares; 2025Q4: 740,000 shares; 2026Q1: 541,000 shares; 2026Q2: 373,000 shares; 2026Q3: 260,250 shares 260,250$5.42M0.29%-112,750Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 42,254 shares; 2026Q3: 57,546 shares 57,546$5.12M0.28%+15,292Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 95,407 shares; 2025Q1: 104,339 shares; 2025Q2: 104,339 shares; 2025Q3: 104,339 shares; 2025Q4: 104,339 shares; 2026Q1: 104,339 shares; 2026Q2: 106,750 shares; 2026Q3: 154,401 shares 154,401$4.3M0.23%+47,651Timeline
NVONOVO-NORDISK A SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 90,000 shares; 2026Q2: 63,500 shares; 2026Q3: 110,800 shares 110,800$4.2M0.23%+47,300Timeline
TLPHTALPHERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 316,460 shares; 2025Q1: 316,460 shares; 2025Q2: 316,460 shares; 2025Q3: 3,589,186 shares; 2025Q4: 3,589,186 shares; 2026Q1: 3,589,186 shares; 2026Q2: 3,589,186 shares; 2026Q3: 3,589,186 shares 3,589,186$4.16M0.22%0Timeline
ABCLABCELLERA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 275,000 shares 275,000$4.01M0.22%newTimeline
MOBIMOBIA MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 418,200 shares; 2026Q3: 418,200 shares 418,200$3.95M0.21%0Timeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,000 shares; 2025Q1: 267,500 shares; 2025Q2: 267,500 shares; 2025Q3: 302,500 shares; 2025Q4: 302,500 shares; 2026Q1: 350,000 shares; 2026Q2: 360,000 shares; 2026Q3: 360,900 shares 360,900$3.72M0.2%+900Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 260,000 shares; 2026Q3: 260,000 shares 260,000$3.72M0.2%0Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 88,750 shares; 2026Q1: 97,000 shares; 2026Q2: 101,000 shares; 2026Q3: 101,250 shares 101,250$3.7M0.2%+250Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,779,575 shares; 2025Q1: 4,962,955 shares; 2025Q2: 4,962,955 shares; 2025Q3: 4,474,702 shares; 2025Q4: 3,927,202 shares; 2026Q1: 3,305,308 shares; 2026Q2: 3,524,929 shares; 2026Q3: 3,524,929 shares 3,524,929$3.67M0.2%0Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 11,100 shares; 2025Q3: 11,100 shares; 2025Q4: 47,000 shares; 2026Q1: 60,250 shares; 2026Q2: 60,250 shares; 2026Q3: 60,250 shares 60,250$3.43M0.18%0Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 98,240 shares; 2026Q1: 170,378 shares; 2026Q2: 235,178 shares; 2026Q3: 383,578 shares 383,578$3.31M0.18%+148,400Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 787,808 shares; 2025Q1: 787,808 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 250,000 shares; 2026Q3: 315,458 shares 315,458$3.12M0.17%+65,458Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 180,000 shares; 2026Q1: 180,000 shares; 2026Q2: 180,000 shares; 2026Q3: 114,654 shares 114,654$2.96M0.16%-65,346Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 345,820 shares; 2026Q1: 383,716 shares; 2026Q2: 383,716 shares; 2026Q3: 383,716 shares 383,716$2.94M0.16%0Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 65,500 shares 65,500$2.92M0.16%newTimeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 61,750 shares 61,750$2.45M0.13%newTimeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 909,103 shares; 2025Q1: 975,803 shares; 2025Q2: 221,500 shares; 2025Q3: 72,965 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 70,103 shares 70,103$2.37M0.13%newTimeline
NGENNERVGEN PHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,208,231 shares; 2026Q3: 1,208,231 shares 1,208,231$2.31M0.12%0Timeline
AVIRATEA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 433,620 shares 433,620$2.26M0.12%newTimeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,304,347 shares; 2026Q2: 1,304,347 shares; 2026Q3: 1,304,347 shares 1,304,347$2.23M0.12%0Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,000 shares; 2026Q2: 40,000 shares; 2026Q3: 25,500 shares 25,500$2.19M0.12%-14,500Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 25,513 shares 25,513$2.03M0.11%newTimeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 116,461 shares 116,461$1.34M0.07%newTimeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,350 shares 3,350$1.28M0.07%newTimeline
BRVEBRAVEHEART BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 60,837 shares 60,837$1.23M0.07%newTimeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 31,655 shares; 2025Q4: 258,739 shares; 2026Q1: 258,739 shares; 2026Q2: 268,519 shares; 2026Q3: 329,170 shares 329,170$1.08M0.06%+60,651Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,500 shares; 2026Q3: 5,500 shares 5,500$1.01M0.05%0Timeline
LENZLENZ THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 29,305 shares; 2025Q1: 83,082 shares; 2025Q2: 83,982 shares; 2025Q3: 236,227 shares; 2025Q4: 257,460 shares; 2026Q1: 257,460 shares; 2026Q2: 257,460 shares; 2026Q3: 257,460 shares 257,460$989K0.05%0Timeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 74,448 shares; 2026Q3: 87,007 shares 87,007$824K0.04%+12,559Timeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 65,000 shares; 2026Q3: 65,000 shares 65,000$742K0.04%0Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 512,132 shares; 2025Q1: 512,932 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 33,800 shares; 2026Q1: 40,500 shares; 2026Q2: 33,500 shares; 2026Q3: 33,500 shares 33,500$666K0.04%0Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 463,088 shares; 2025Q1: 545,171 shares; 2025Q2: 545,171 shares; 2025Q3: 1,100,726 shares; 2025Q4: 1,100,726 shares; 2026Q1: 1,100,726 shares; 2026Q2: 1,100,726 shares; 2026Q3: 1,100,726 shares 1,100,726$638K0.03%0Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 99,429 shares; 2025Q2: 99,429 shares; 2025Q3: 99,429 shares; 2025Q4: 99,429 shares; 2026Q1: 99,429 shares; 2026Q2: 99,429 shares; 2026Q3: 99,429 shares 99,429$523K0.03%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 23,778 shares 23,778$296K0.02%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,677,996 shares; 2025Q1: 222,011 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 12,600 shares; 2026Q2: 22,124 shares; 2026Q3: 22,124 shares 22,124$184K0.01%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MDTMEDTRONIC PLC30,900$2.42Mshares
TEVATEVA PHARMACEUTICAL INDS LTD59,000$2Mshares
DNTHDIANTHUS THERAPEUTICS INC20,326$1.98Mshares
ALTALTIMMUNE INC471,465$1.43Mshares
SGRYSURGERY PARTNERS INC84,000$1.41Mshares
ORKAORUKA THERAPEUTICS INC12,051$1.15Mshares
VKTXVIKING THERAPEUTICS INC25,500$995Kshares
GKOSGLAUKOS CORP4,750$664Kshares
MLTXMOONLAKE IMMUNOTHERAPEUTICS10,696$208Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-26-005279 base2026-11-16